edgepedia

Medical and health researchers

8,517 articles

Mark D. Perkins

Mark D. Perkins is an American infectious-disease diagnostics researcher who co-founded FIND in Geneva, was its Chief Scientific Officer, and co-authored the 2010 Xpert MTB/RIF tuberculosis study.

Mark E. Anderson

Mark E. Anderson is an American cardiac electrophysiologist and physician-scientist who became Dean of the Pritzker School of Medicine at the University of Chicago in 2022.

Mark E. Brezinski

Mark E. Brezinski is an American cardiologist and physician-scientist who pioneered optical coherence tomography imaging of coronary arteries, detecting vulnerable plaques, and received the 1999 Presidential Early Career Award.

Mark E. Cooper

Mark E. Cooper, also known as Mark Cooper, is an Australian professor of diabetes at Monash University known for research on diabetic kidney disease and complications.

Mark E. Ewen

Mark E. Ewen is a cancer biologist at Dana-Farber Cancer Institute and Harvard Medical School in Boston whose research concerns cell division control, notably the retinoblastoma protein and cyclin D1.

Mark E. Josephson

Mark E. Josephson (1943–2017) was an American cardiologist who pioneered clinical cardiac electrophysiology, standardized left ventricular mapping enabling catheter ablation of ventricular tachycardia, and led programs at Penn and Harvard's Beth Israel.

Mark E. Molitch

Mark E. Molitch is an American endocrinologist and Professor Emeritus of Medicine at Northwestern University Feinberg School of Medicine, known for research on pituitary tumors, prolactinomas, and diabetes.

Mark Edwin Frisse

Mark Edwin Frisse is an American physician and medical informatician, emeritus Accenture Professor of Biomedical Informatics at Vanderbilt, known for clinical decision support systems and the Memphis health information exchange.

Mark F. Newman

Mark F. Newman is an American anesthesiologist who chaired Duke Anesthesiology from 2001 to 2014 and is best known for research on cognitive decline after coronary artery bypass surgery.

Mark Feldman

Mark Feldman (1947–2024) was an American gastroenterologist in Dallas, Texas, known for research on gastric acid secretion and as an editor of Sleisenger and Fordtran's Gastrointestinal and Liver Disease.

Mark G. Kris

Mark G. Kris is an American thoracic medical oncologist and emeritus member of Memorial Sloan Kettering, known for clinical trials bringing EGFR-targeted therapy into lung cancer practice.

Mark H. Kaplan

Mark H. Kaplan is an American immunologist at the Indiana University School of Medicine known for defining how STAT4 and STAT6 control T helper cell differentiation.

Mark Hallett (neurologist)

Mark Hallett (1943–2025) was an American neurologist who led the Human Motor Control Section at NINDS in Bethesda for four decades, pioneering transcranial magnetic stimulation and research on dystonia and Parkinson's disease.

Mark J Bolland

Mark J Bolland is a New Zealand endocrinologist and Associate Professor at the University of Auckland, known for trials and meta-analyses on calcium, vitamin D, and zoledronate.

Mark J. Caulfield

Sir Mark Caulfield is a British clinical pharmacologist at Queen Mary University of London who was Chief Scientist of Genomics England from 2013 to 2021.

Mark J. Koury

Mark J. Koury is an American hematology researcher at Vanderbilt University School of Medicine in Nashville whose 1986 work with Maurice Bondurant showed that hypoxia raises kidney erythropoietin production by increasing EPO messenger RNA.

Mark J. Levis

Mark J. Levis is a hematologist-oncologist and professor at Johns Hopkins who directs the Adult Leukemia Service and led the ADMIRAL trial of gilteritinib for FLT3-mutated acute myeloid leukemia.

Mark J. Ratain

Mark J. Ratain, born 1954, is an American oncologist at the University of Chicago known for cancer pharmacogenetics, phase I trial design, and the UGT1A1 work behind the 2005 irinotecan label change.

Mark J. Sarnak

Mark J. Sarnak is a nephrologist and Friedman Professor of Medicine at Tufts, known for reframing chronic kidney disease as a major cardiac risk factor.

Mark K. Jenkins

Mark K. Jenkins, published as Marc K. Jenkins, is an American immunologist whose 1987 work with Ronald Schwartz showed that T cells lacking co-stimulation become anergic.

Mark L. Kahn

Mark L. Kahn is an American physician-scientist in hematology and vascular biology at the University of Pennsylvania, known for work on platelet receptors and cerebral cavernous malformations.

Mark L. Rosenberg

Mark L. Rosenberg (born 1945) is an American physician and public health researcher who founded the CDC's injury prevention center and led The Task Force for Global Health.

Mark L. Zeidel

Mark L. Zeidel is an American kidney and membrane physiologist whose 1992 purified-protein proof that CHIP28 conducts water is cited in the 2003 Nobel Prize in Chemistry background.

Mark Leppert

Mark F. Leppert is an American human geneticist at the University of Utah who mapped genes for inherited diseases, with major work on colorectal cancer, epilepsy, and macular degeneration.

Mark Levine (physician-scientist)

Mark Levine is an American physician-scientist who leads the Molecular and Clinical Nutrition Section at NIH, studying vitamin C needs and its intravenous use against cancer.

Mark M. Awad

Mark M. Awad, known professionally as Mark Awad, is a thoracic medical oncologist and chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center in New York.

Mark N. Levine

Mark N. Levine is a Canadian medical oncologist and Professor Emeritus at McMaster University whose trials shortened chemotherapy after breast cancer surgery and reshaped radiotherapy.

Mark Olfson

Mark Olfson is an American psychiatrist and psychiatric epidemiologist at Columbia University Medical Center, known for national studies of mental health care, suicide prevention, and premature mortality in schizophrenia.

Mark P. Mattson

Mark P. Mattson is an American neuroscientist known for research on brain aging and intermittent fasting, and Chief of the National Institute on Aging's Laboratory of Neurosciences from 2000 to 2019.

Mark R. Haussler

Mark R. Haussler is an American molecular endocrinologist at the University of Arizona known for identifying the renal vitamin D hormone and discovering the vitamin D receptor.